ClinicalTrials.govpublic full text
BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
inflammatory bowel diseases (ibd), ulcerative colitis, crohn's disease, inflammatory bowel disease, ibd, uc, cd, car-t, cellular therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845504
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.